
A Glance at 2025-2026 Flu Seasons
According to the CDC, a look back at April 2026 cumulative reports showed more than 139 pediatric deaths with approximately 250,000 people hospitalized. In simple

According to the CDC, a look back at April 2026 cumulative reports showed more than 139 pediatric deaths with approximately 250,000 people hospitalized. In simple

Atossa Therapeutics Inc. has achieved a significant regulatory milestone with the U.S. Food and Drug Administration’s grant of Rare Pediatric Disease (RPD) designation to (Z)-endoxifen

An article from University of Michigan highlighted Jolanta Grembecka and her husband Tomasz Cierpicki, both assistant professors in U of M’s Department of Pathology, who

Milenia Makani is an abstract artist living in London. She lives with Hypermobile Ehlers-Danlos Syndrome (hEDS), and has launched an international art fundraiser to support

What happens when a pharmaceutical first-mover discovers its historic achievement may not be a blockbuster? Arvinas and Pfizer found an answer this week by handing

What is Parkinson’s Disease – known as PD for short? Parkinson’s Disease was first discovered in 1817 by a British doctor named James Parkinson. From

A recent article by Dr. Rosalie Greenberg explores the possible relationship of infections caused by ticks and psychiatric conditions in children, including PANS or PANDA

Abeona Therapeutics Inc. has announced a significant expansion in access to ZEVASKYN, marking the activation of Children’s Hospital of Philadelphia (CHOP) as the sixth Qualified

As reported on PharmaBiz, Regenxbio has announced encouraging topline findings from the pivotal Phase III portion of its ongoing AFFINITY DUCHENNE clinical program evaluating RGX-202,

Biossil, based in Toronto and co-founded by Dr. Alexander Mosa (Chair, CSO and co-founder) and Anthony Mouchantaf (CEO and co-founder), is making headway for rare

As reported on PharmaTimes, Poolbeg Pharma has secured a Canadian patent protecting the use of p38 MAPK inhibitors, including its lead candidate POLB 001, for preventing

Editor’s Note: This story was originally published on Linked-In and is shared with permission by Olga Lucia Torres. She waited an hour and fifteen minutes to

As reported on Healio, emerging real-world evidence suggests that glucagon-like peptide-1 (GLP-1) receptor agonists—and related dual agonists—may play a significant role in lowering the risk

I remember the day I realized something was wrong, as clearly as if it happened this past weekend. It was a beautiful morning in June.

Systemic lupus erythematosus punishes patients twice. First comes the disease itself, an autoimmune disorder where the body attacks its own tissues, causing debilitating fatigue, joint
As reported on BioSpace, the U.S. Food and Drug Administration (FDA) has approved Partner Therapeutics’ bispecific antibody Bizengri for adults with cholangiocarcinoma harboring an NRG1

Editor’s Note: Patient Worthy is honored to share this submission from Katie DiLorenzo, SVP, Patient and Pharmacy Services, PANTHERx® Rare. If you’re living with a

Mesenchymal stromal cells (MSCs) have tantalized the medical world for years. These versatile immune-modulating cells offer genuine hope for diseases ranging from epidermolysis bullosa, a
Living with COPD can be challenging, but effective management goes beyond medication alone. From pulmonary rehabilitation and oxygen therapy to lifestyle changes and preventive care, a comprehensive treatment plan can help improve breathing, increase independence, and enhance quality of life.
Understanding available treatment options empowers individuals to take an active role in their care and work toward better respiratory health—one breath at a time. 💙🫁
Click the link below to share!
bit.ly/3VuxFDV
#copd #COPDawareness #PatientWorthy
... See MoreSee Less


+1
To anyone living with a rare or chronic illness: Having to explain your condition over and over doesn’t make you “difficult”—it speaks to your resilience. It shows the strength it takes to advocate for yourself, to be heard, and to keep going in ways most people don’t see. Even on the days when you’re exhausted from repeating your story, your experience is valid. The emotional labor behind this journey isn’t talked about enough, and this is for everyone who’s had to explain their condition one too many times. 💙 #ChronicIllnessAwareness #RareDisease #InvisibleIllness #PatientWorthy #Support #Compassion #Empathy ... See MoreSee Less


+3
Appointments can feel overwhelming, but sometimes the smallest preparations can make the biggest difference. Writing down questions, tracking symptoms, bringing a support person, or simply giving yourself time to decompress afterward can help make each visit a little more manageable. Every appointment is a step toward understanding, advocating for, and caring for your health. And that matters!
What is one thing that helps make appointments easier for you?
#patientadvocacy #healthtips #PatientWorthy
... See MoreSee Less

© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.